248
Participants
Start Date
January 7, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
Pivmecillinam
Orally administered pivmecillinam 400mg
Pivmecillinam
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Amoxicillin clavulanic acid
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Amoxicillin
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Cefuroxime
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Ciprofloxacin
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Linezolid
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Nitrofurantoin
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Trimethoprim
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Sulfamethoxazole trimethoprim
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Fluconazole
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
RECRUITING
Department of Urology, Rigshospitalet, Copenhagen
NOT_YET_RECRUITING
Department of Urology, Herlev and Gentofte Hospital, Herlev
NOT_YET_RECRUITING
Department of Urology, Odense University Hospital, Odense
NOT_YET_RECRUITING
Department of Urology, Aarhus University Hospital, Aarhus
NOT_YET_RECRUITING
Department of Urology, Aalborg University Hospital, Aalborg
Rigshospitalet, Denmark
OTHER